Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-trial access program of sacubitril/valsartan for pediatric heart failure after PANORAMA-HF OLE completion
MOH_2024-01-07_013165Phase 3Completed
- Sponsor
- ד"ר אביבה לויטס
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sacubitril + valsartan in heart failure (HF), sponsored by ד"ר אביבה לויטס. Started Dec 2023; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on MOH_2024-01-07_013165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2024-01-07_013165.